BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 10217190)

  • 21. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
    van Kraaij MG; Verdonck LF; Rozenberg-Arska M; Dekker AW
    Bone Marrow Transplant; 2002 Sep; 30(5):303-9. PubMed ID: 12209352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J; Akard LP; Wack MF; Thompson JM; Dugan MJ; Leslie JK; Mattison R
    Mycoses; 2006 Sep; 49(5):397-404. PubMed ID: 16922792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
    Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection.
    Safdar A; Papadopoulous EB; Armstrong D
    Bone Marrow Transplant; 2002 Jun; 29(11):913-6. PubMed ID: 12080357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants.
    García S; Roque J; Ruza F; González M; Madero R; Alvarado F; Herruzo R
    Clin Transplant; 1998 Jun; 12(3):190-7. PubMed ID: 9642509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infections following bone marrow transplantation].
    Ljungman P; Andersson J; Sparrelid E
    Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
    Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
    Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
    Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
    Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
    Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
    Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
    Toor AA; van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
    Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.